title: Cytomegalovirus associated transverse myelitis in an immunocompetent host with DNA detection in cerebrospinal fluid; a case report.
abstract: BACKGROUND
  Cytomegalovirus associated transverse myelitis among immunocompetent adults has been rarely reported. We report a patient presenting with clinical myelitis followed by previously unreported finding of cytomegalovirus deoxyribonucleic acid in cerebrospinal fluid.
  
  
  METHODS
  A forty year old immunocompetent male presented with acute onset progressive bilateral lower limb weakness. His spinal magnetic resonance imaging findings, cerebrospinal fluid analysis and clinical picture were compatible with transverse myelitis. Polymerase chain reaction of the cerebrospinal fluid for cytomegalovirus was positive while other infectious agents were not detected by serology or polymerase chain reaction. He was treated with intravenous ganciclovir with partial clinical response.
  
  
  CONCLUSIONS
  Viral genome detection in the cerebrospinal fluid was performed but negative in five out of ten reported cases of cytomegalovirus associated transverse myelitis in the immunocompetent host. In previous cases the inability to isolate the virus in cerebrospinal fluid was considered favouring an immunological mechanism leading to pathogenesis rather than direct viral toxicity but this case is against that theory. This case highlights the fact that Cytomegalovirus should be considered as an aetiological agent in patients with transverse myelitis and that the virus may cause serious infections in immunocompetent host. Therefore this report is of importance to neurologists and physicians in general.
authors: National hospital of Sri Lanka, Regent street, Colombo, Sri Lanka. suneth871@gmail.com
authors: Suneth
authors: S
authors: Karunarathne
authors: Dumitha
authors: D
authors: Govindapala
authors: Yapa
authors: Y
authors: Udayakumara
authors: Harshini
authors: H
authors: Fernando
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000472:pathogenicity / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D004279:DNA, Viral / Q000134:cerebrospinal fluid*; D015774:Ganciclovir / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007121:Immunocompetence; D008297:Male; D009188:Myelitis, Transverse / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D016133:Polymerase Chain Reaction
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D015774:Ganciclovir